Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05339555 · ClinicalTrials.gov registry record · NA
IUD Self-Removal Study
A NA study of IUD, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05339555: Recruiting NA study of IUD, sponsored by Oregon Health and Science University.
NCT05339555 is a NA study of IUD that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 30 participants, below the 246-participant average among 5 other IUD trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05339555, a NA study of IUD, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study designed to test the effectiveness of several techniques for intrauterine device (IUD) self-removal and to understand patient preferences regarding IUD self-removal and indicators of success as well as understanding the impacts of IUD self-removal on other clinical care.
Primary Outcome
Proportion of participants who successfully remove their IUDs
Conditions Studied
Interventions
- OTHER Instructions for IUD Self-Removal Provided to Participant
Study Locations (1)
Oregon
- Oregon Health & Science Univeristy - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-06-10 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT05339555 shows while recruiting
NCT05339555 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 246-participant average among 5 other IUD trials with a reported enrollment target (88% lower).
The record links to 1 condition, with IUD appearing as the primary indexed condition, and to 1 intervention - of which Instructions for IUD Self-Removal Provided to Participant is the first listed.
NCT05339555 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05339555 about?
NCT05339555 is a clinical study titled "IUD Self-Removal Study". This is a pilot study designed to test the effectiveness of several techniques for intrauterine device (IUD) self-removal and to understand patient preferences regarding IUD self-removal and indicators of success as well as understanding the impacts of IUD self-removal on other clinical care.
What is the current status of trial NCT05339555?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-06-10. Estimated completion is 2025-12-31.
What conditions does trial NCT05339555 study?
This clinical trial studies the following conditions: IUD.
What interventions are being tested in trial NCT05339555?
The interventions under investigation include: Instructions for IUD Self-Removal Provided to Participant (OTHER).
Who is sponsoring clinical trial NCT05339555?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05339555 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for IUD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TENS Unit for Analgesia During IUD Insertion
RECRUITING · NA
-
Use of Cervical Cap and Menstrual Disc for Application of Topical Anesthetic Prior to IUD Insertion
RECRUITING · NA
-
IUD Self-Removal: Evaluating an Online Guide for Self-removal in Clinical and Non-clinical Settings
COMPLETED · NA
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Quick Start of Highly Effective Contraception
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI